Monographie - Hydrocortisone - Stabilis 4.0

Ultimo aggiornamento :
19/11/2024

Antinfiammatorio

Hydrocortisone

Soluzione orale

sacchetti di carta

Stabilità dei preparati farmaceutici

Stabilità in miscela

Fattori che influenzano la stabilità

Compatibilità

Bibliografia

pdf

Struttura chimica

Soluzione orale

Bibliografia

Soluzione orale

Bibliografia : Hydrocortisone

	tipo	pubblicazione
909	Rivista	Chong G, Decarie D, Ensom M.H.H. Stability of hydrocortisone in extemporaneously compounded suspensions. J Informed Pharmacother 2003 ; 13: 100-110.
2538	Rivista	Fawcett JP, Boulton DW, Jiang R, Woods DJ. Stability of hydrocortisone oral suspensions prepared from tablets and powder. Ann Pharmacotherapy 1995 ;29:987-990.
2835	Rivista	Das Gupta V. Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents Int J Pharm Compound 2007 ; 11, 3: 259-261.
3755	Rivista	Bourget P, Amin A, Vidal F, Pieyre M, Dosso E.O, Beauvais R, Loeuillet R. Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition. Int J Pharm Compound 2014 ; 18, 5: 427-431.
3810	Rivista	Geiger C M, Sorenson B, Whaley P. Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF. Int J Pharm Compound 2015 ; 19, 5 : 420-427.
3811	Rivista	Nahata Milap C. Stability of Levothyroxine, Doxycycline, Hydrocortisone, and Pravastatin in Liquid Dosage Forms Stored at Two Temperatures. Int J Pharm Compound 2015 ; 19, 5 : 428-431.
4063	Rivista	Manchanda A, Laracy M, Savji T, Bogner R. Stability of an Alcohol-free, Dye-free Hydrocortisone (2mg/mL) Compounded Oral Suspension. Int J Pharm Compound 2018 ;22,1:66-75
4198	Rivista	Uriel M, Gomez-Rincon C, Marro D. Stability of regularly prescribed oral liquids formulated with SyrSpend® SF. Pharmazie 2018 73;196-201
4530	Rivista	Pramar Y, Mandal T, Bostanian L, Kader C, Morris T, Graves R. Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt. Int J Pharm Compound 2021 ;25,5:431-439

Mentions Légales